Rare diseases
Investigational molecules
Locations
Back to Germany3 clinical trials in Erkelenz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on triple-negative breast cancer evaluating the effectiveness of combining immunotherapy with traditional chemotherapy treatments. Studies aim to improve patient outcomes through personalized therapeutic approaches.
Research explores novel combination therapies to enhance treatment efficacy.
Studies examining personalized treatment strategies for HR+/HER2- breast cancer patients, comparing endocrine therapy combinations with standard chemotherapy approaches. Focus on long-term survival outcomes.
Investigation of targeted therapies to improve treatment effectiveness.
Research evaluating novel therapeutic approaches for HER2-negative breast cancer patients, particularly those at high risk of relapse after standard treatments. Focus on comparing innovative targeted therapies with conventional approaches.
Development of targeted solutions for challenging breast cancer cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
